Cardiovascular Disease Prevention in Men with Vascular Erectile Dysfunction: The View of the Preventive Cardiologist

Nishant P. Shah, Miguel Cainzos-Achirica, David I. Feldman, Roger S Blumenthal, Khurram Nasir, Martin M. Miner, Kevin Lenuell Billups, Michael Blaha

Research output: Contribution to journalArticle

Abstract

Vascular erectile dysfunction is a powerful marker of increased cardiovascular risk. However, current guidelines lack specific recommendations on the role that the evaluation of vascular erectile dysfunction should play in cardiovascular risk assessment, as well on the risk stratification strategy that men with vascular erectile dysfunction should undergo. In the last 3 years, erectile dysfunction experts have made a call for more specific guidance and have proposed the selective use of several prognostic tests for further cardiovascular risk assessment in these patients. Among them, stress testing has been prioritized, whereas other tests are considered second-line tools. In this review, we provide additional perspective from the viewpoint of the preventive cardiologist. We discuss the limitations of current risk scores and the potential interplay between erectile dysfunction assessment and the use of personalized prognostic tools, such as the coronary artery calcium score, in the cardiovascular risk stratification and management of men with vascular erectile dysfunction. Finally, we present an algorithm for primary care physicians, urologists, and cardiologists to aid clinical decision-making.

Original languageEnglish (US)
Pages (from-to)251-259
Number of pages9
JournalAmerican Journal of Medicine
Volume129
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Erectile Dysfunction
Blood Vessels
Cardiovascular Diseases
Risk Management
Primary Care Physicians
Cardiologists
Coronary Vessels
Guidelines
Calcium

Keywords

  • Atherosclerosis
  • Cardiovascular disease
  • Coronary artery calcium
  • Erectile dysfunction
  • Prevention
  • Risk
  • Vascular erectile dysfunction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cardiovascular Disease Prevention in Men with Vascular Erectile Dysfunction : The View of the Preventive Cardiologist. / Shah, Nishant P.; Cainzos-Achirica, Miguel; Feldman, David I.; Blumenthal, Roger S; Nasir, Khurram; Miner, Martin M.; Billups, Kevin Lenuell; Blaha, Michael.

In: American Journal of Medicine, Vol. 129, No. 3, 01.03.2016, p. 251-259.

Research output: Contribution to journalArticle

Shah, Nishant P. ; Cainzos-Achirica, Miguel ; Feldman, David I. ; Blumenthal, Roger S ; Nasir, Khurram ; Miner, Martin M. ; Billups, Kevin Lenuell ; Blaha, Michael. / Cardiovascular Disease Prevention in Men with Vascular Erectile Dysfunction : The View of the Preventive Cardiologist. In: American Journal of Medicine. 2016 ; Vol. 129, No. 3. pp. 251-259.
@article{0476951cc0a74136a47d302030ac18fd,
title = "Cardiovascular Disease Prevention in Men with Vascular Erectile Dysfunction: The View of the Preventive Cardiologist",
abstract = "Vascular erectile dysfunction is a powerful marker of increased cardiovascular risk. However, current guidelines lack specific recommendations on the role that the evaluation of vascular erectile dysfunction should play in cardiovascular risk assessment, as well on the risk stratification strategy that men with vascular erectile dysfunction should undergo. In the last 3 years, erectile dysfunction experts have made a call for more specific guidance and have proposed the selective use of several prognostic tests for further cardiovascular risk assessment in these patients. Among them, stress testing has been prioritized, whereas other tests are considered second-line tools. In this review, we provide additional perspective from the viewpoint of the preventive cardiologist. We discuss the limitations of current risk scores and the potential interplay between erectile dysfunction assessment and the use of personalized prognostic tools, such as the coronary artery calcium score, in the cardiovascular risk stratification and management of men with vascular erectile dysfunction. Finally, we present an algorithm for primary care physicians, urologists, and cardiologists to aid clinical decision-making.",
keywords = "Atherosclerosis, Cardiovascular disease, Coronary artery calcium, Erectile dysfunction, Prevention, Risk, Vascular erectile dysfunction",
author = "Shah, {Nishant P.} and Miguel Cainzos-Achirica and Feldman, {David I.} and Blumenthal, {Roger S} and Khurram Nasir and Miner, {Martin M.} and Billups, {Kevin Lenuell} and Michael Blaha",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.amjmed.2015.08.038",
language = "English (US)",
volume = "129",
pages = "251--259",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Cardiovascular Disease Prevention in Men with Vascular Erectile Dysfunction

T2 - The View of the Preventive Cardiologist

AU - Shah, Nishant P.

AU - Cainzos-Achirica, Miguel

AU - Feldman, David I.

AU - Blumenthal, Roger S

AU - Nasir, Khurram

AU - Miner, Martin M.

AU - Billups, Kevin Lenuell

AU - Blaha, Michael

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Vascular erectile dysfunction is a powerful marker of increased cardiovascular risk. However, current guidelines lack specific recommendations on the role that the evaluation of vascular erectile dysfunction should play in cardiovascular risk assessment, as well on the risk stratification strategy that men with vascular erectile dysfunction should undergo. In the last 3 years, erectile dysfunction experts have made a call for more specific guidance and have proposed the selective use of several prognostic tests for further cardiovascular risk assessment in these patients. Among them, stress testing has been prioritized, whereas other tests are considered second-line tools. In this review, we provide additional perspective from the viewpoint of the preventive cardiologist. We discuss the limitations of current risk scores and the potential interplay between erectile dysfunction assessment and the use of personalized prognostic tools, such as the coronary artery calcium score, in the cardiovascular risk stratification and management of men with vascular erectile dysfunction. Finally, we present an algorithm for primary care physicians, urologists, and cardiologists to aid clinical decision-making.

AB - Vascular erectile dysfunction is a powerful marker of increased cardiovascular risk. However, current guidelines lack specific recommendations on the role that the evaluation of vascular erectile dysfunction should play in cardiovascular risk assessment, as well on the risk stratification strategy that men with vascular erectile dysfunction should undergo. In the last 3 years, erectile dysfunction experts have made a call for more specific guidance and have proposed the selective use of several prognostic tests for further cardiovascular risk assessment in these patients. Among them, stress testing has been prioritized, whereas other tests are considered second-line tools. In this review, we provide additional perspective from the viewpoint of the preventive cardiologist. We discuss the limitations of current risk scores and the potential interplay between erectile dysfunction assessment and the use of personalized prognostic tools, such as the coronary artery calcium score, in the cardiovascular risk stratification and management of men with vascular erectile dysfunction. Finally, we present an algorithm for primary care physicians, urologists, and cardiologists to aid clinical decision-making.

KW - Atherosclerosis

KW - Cardiovascular disease

KW - Coronary artery calcium

KW - Erectile dysfunction

KW - Prevention

KW - Risk

KW - Vascular erectile dysfunction

UR - http://www.scopus.com/inward/record.url?scp=84958054157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958054157&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2015.08.038

DO - 10.1016/j.amjmed.2015.08.038

M3 - Article

C2 - 26477950

AN - SCOPUS:84958054157

VL - 129

SP - 251

EP - 259

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 3

ER -